NCT04077242

Brief Summary

Hysteroscopy is an important tool in the evaluation of sterility. Assessing tubal patency during hysteroscopy seems highly relevant, particularly when it allows for a low cost, fast, gentle, and accurate way of gathering information that may guide clinical care. Therefore, it is important to know which technique is the best. Thus, the primary aim of this study is to evaluate the reliability of (1.) the hysteroscopic visualization of a "tubal flow" and (2.) the "Parryscope technique" as compared to the gold standard, namely laparoscopic chromopertubation. In a prospective, randomized study, the following women are enrolled: (1.) The patient is subfertile, defined as being unable to become pregnant within a year despite unprotected sexual intercourse. It is also within the standard of care to be presumed subfertile if one has tried for six months and has known risk factors that would hinder conception, including but not limited to anovulation and endometriosis. (2.) A concurrent diagnostic hysteroscopy and laparoscopy with chromopertubation are performed at the Clinical Division of Gynecological Endocrinology and Reproductive Medicine at the Medical University of Vienna. Hysteroscopic evaluation of tubal patency (either by a positive "tubal flow" or a visible flow of air bubbles in the "Parryscope technique") and the result of the laparoscopic chromopertubation (tubal patency existing or not existing) will be the primary outcome parameters. A total 60 patients are enrolled (30 patients in the "flow assessment" group, 30 patients in the "Parryscope" group) and randomization is performed as block randomization in 4 blocks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 31, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 24, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 4, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2019

Completed
Last Updated

December 12, 2019

Status Verified

December 1, 2019

Enrollment Period

5 months

First QC Date

August 24, 2019

Last Update Submit

December 11, 2019

Conditions

Keywords

hysteroscopyParryscopechromopertubation

Outcome Measures

Primary Outcomes (1)

  • Fallopian tube patency using laparoscopic chromopertubation

    tubal patency as assessed by chromopertubation (information provided separately for each side)

    In the course of subsequent laparoscopy, i.e. 20-60 minutes after the diagnostic intervention

Study Arms (2)

"Parryscope"-group

ACTIVE COMPARATOR

In these patients, Fallopian tube patency is assessed using the "Parryscope" technique. A small amount of air is introduced into the iv tubing by inverting the drip chamber to create air bubbles. When air enters the uterine cavity, a single large air bubble or stream of air bubbles traversing the ostia is considered indicative of tubal patency. At least 10 seconds of intracavitary evaluation is typically performed before air bubble entry to allow pressure equilibration if a hydrosalpinx is present \[10\]. At least 30 seconds of observation per ostia is performed if patency is not observed.

Diagnostic Test: Hysteroscopic Fallopian tube assessment using the "Parryscope" technique

"Tubal flow"-group

ACTIVE COMPARATOR

In these patients, Fallopian tube patency is assessed using the "flow" technique. a positive "flow" is defined as the observation of saline directly traversing the ostia, endometrial structures floating toward the ostia, or air bubbles traversing the ostia.

Diagnostic Test: Hysteroscopic Fallopian tube assessment using the "Tubal flow" technique

Interventions

A small amount of air is introduced into the iv tubing by inverting the drip chamber to create air bubbles. When air enters the uterine cavity, a single large air bubble or stream of air bubbles traversing the ostia is considered indicative of tubal patency. At least 10 seconds of intracavitary evaluation is typically performed before air bubble entry to allow pressure equilibration if a hydrosalpinx is present \[10\]. At least 30 seconds of observation per ostia is performed if patency is not observed.

"Parryscope"-group

a positive "flow" is defined as the observation of saline directly traversing the ostia, endometrial structures floating toward the ostia, or air bubbles traversing the ostia.

"Tubal flow"-group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • The patient is subfertile, defined as being unable to become pregnant within a year despite unprotected sexual intercourse. It is also within the standard of care to be presumed subfertile if one has tried for six months and has known risk factors that would hinder conception, including but not limited to anovulation and endometriosis.
  • A concurrent diagnostic hysteroscopy and laparoscopy with chromopertubation are performed at the Clinical Division of Gynecological Endocrinology and Reproductive Medicine at the Medical University of Vienna.
  • The patient has given her written informed consent after detailed information on the study by medical professionals at the Department of Obstetrics and Gynecology of the Medical University of Vienna.
  • The patient is over 18 and under 45 years old.

You may not qualify if:

  • The patient had a tubectomy on one or both sides.
  • There is no "informed consent".
  • The patients has active vaginal infection or other conditions that would preclude hysteroscopy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Vienna, Clinical Division of Gynecologic Endocrinology and Reproductive Medicine

Vienna, 1090, Austria

Location

Related Publications (13)

  • Cholkeri-Singh A, Sasaki KJ. Hysteroscopy for infertile women: a review. J Minim Invasive Gynecol. 2015 Mar-Apr;22(3):353-62. doi: 10.1016/j.jmig.2014.12.163. Epub 2014 Dec 29.

    PMID: 25553895BACKGROUND
  • Godinjak Z, Idrizbegovic E. Should diagnostic hysteroscopy be a routine procedure during diagnostic laparoscopy in infertile women? Bosn J Basic Med Sci. 2008 Feb;8(1):44-7. doi: 10.17305/bjbms.2008.2996.

    PMID: 18318671BACKGROUND
  • Indraccolo U, Greco P, Scutiero G, Marrocchella S, Sorrentino F, Mastricci L, Matteo M. The role of hysteroscopy in the diagnostic work-up of infertile asymptomatic patients. Clin Exp Obstet Gynecol. 2014;41(2):124-7.

    PMID: 24779234BACKGROUND
  • Mahran A, Abdelraheim AR, Eissa A, Gadelrab M. Does laparoscopy still has a role in modern fertility practice? Int J Reprod Biomed. 2017 Dec;15(12):787-794.

    PMID: 29492476BACKGROUND
  • Zhang E, Zhang Y, Fang L, Li Q, Gu J. Combined hysterolaparoscopy for the diagnosis of female infertility: a retrospective study of 132 patients in china. Mater Sociomed. 2014 Jun;26(3):156-7. doi: 10.5455/msm.2014.26.156-157. Epub 2014 Jun 21.

    PMID: 25126006BACKGROUND
  • Parry JP, Isaacson KB. Hysteroscopy and why macroscopic uterine factors matter for fertility. Fertil Steril. 2019 Aug;112(2):203-210. doi: 10.1016/j.fertnstert.2019.06.031.

    PMID: 31352959BACKGROUND
  • Promberger R, Simek IM, Nouri K, Obermaier K, Kurz C, Ott J. Accuracy of Tubal Patency Assessment in Diagnostic Hysteroscopy Compared with Laparoscopy in Infertile Women: A Retrospective Cohort Study. J Minim Invasive Gynecol. 2018 Jul-Aug;25(5):794-799. doi: 10.1016/j.jmig.2017.11.020. Epub 2017 Dec 6.

    PMID: 29221993BACKGROUND
  • Hager M, Simek IM, Promberger R, Ott J. The Role of Diagnostic Hysteroscopy in the Evaluation of Fallopian Tube Patency: a Short Review. Geburtshilfe Frauenheilkd. 2019 May;79(5):483-486. doi: 10.1055/a-0826-1326. Epub 2019 May 21.

    PMID: 31148848BACKGROUND
  • Habibaj J, Kosova H, Bilali S, Bilali V, Qama D. Comparison between transvaginal sonography after diagnostic hysteroscopy and laparoscopic chromopertubation for the assessment of tubal patency in infertile women. J Clin Ultrasound. 2012 Feb;40(2):68-73. doi: 10.1002/jcu.20883. Epub 2011 Sep 20.

    PMID: 21935964BACKGROUND
  • Parry JP, Riche D, Aldred J, Isaacs J, Lutz E, Butler V, Shwayder J. Proximal Tubal Patency Demonstrated Through Air Infusion During Flexible Office Hysteroscopy Is Predictive of Whole Tubal Patency. J Minim Invasive Gynecol. 2017 May-Jun;24(4):646-652. doi: 10.1016/j.jmig.2017.02.010. Epub 2017 Feb 16.

    PMID: 28216455BACKGROUND
  • Torok P, Major T. Accuracy of assessment of tubal patency with selective pertubation at office hysteroscopy compared with laparoscopy in infertile women. J Minim Invasive Gynecol. 2012 Sep-Oct;19(5):627-30. doi: 10.1016/j.jmig.2012.03.016.

    PMID: 22935304BACKGROUND
  • Parry JP, Riche D, Rushing J, Linton B, Butler V, Lindheim SR. Performing the Parryscope technique gently for office tubal patency assessment. Fertil Steril. 2017 Oct;108(4):718. doi: 10.1016/j.fertnstert.2017.07.1159. Epub 2017 Aug 31.

    PMID: 28843382BACKGROUND
  • Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform. 2014 Apr;48:193-204. doi: 10.1016/j.jbi.2014.02.013. Epub 2014 Feb 26.

    PMID: 24582925BACKGROUND

MeSH Terms

Conditions

Infertility, FemaleUterine Anomalies

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesInfertility

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc.Prof. Priv.Doz. Dr.

Study Record Dates

First Submitted

August 24, 2019

First Posted

September 4, 2019

Study Start

May 31, 2019

Primary Completion

October 25, 2019

Study Completion

October 25, 2019

Last Updated

December 12, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Data will be provided on personal request

Locations